Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives |
| |
Authors: | Beaulieu Pierre L Bös Michael Bousquet Yves Fazal Gulrez Gauthier Jean Gillard James Goulet Sylvie LaPlante Steven Poupart Marc-André Lefebvre Sylvain McKercher Ginette Pellerin Charles Austel Volkhard Kukolj George |
| |
Affiliation: | Department of Chemistry, Boehringer Ingelheim (Canada) Ltd, Research and Development, 2100 Cunard Street, H7S 2G5, Laval (Québec), Canada. pbeaulieu@lav.boehringer-ingelheim.com |
| |
Abstract: | Benzimidazole 5-carboxamide derivatives from a combinatorial screening library were discovered as specific inhibitors of the NS5B polymerase of the hepatitis C virus (HCV). Initial hit-to-lead activities taking advantage of high-throughput parallel synthetic techniques, identified a 1,2-disubstituted benzimidazole 5-carboxylic acid scaffold as the minimum core for biological activity. Potent analogues in this series inhibit the polymerase at low micromolar concentrations and provide an attractive "drug-like" lead structure for further optimization and the development of potential HCV therapeutics. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|